FERRONI, PATRIZIA
 Distribuzione geografica
Continente #
NA - Nord America 7.720
AS - Asia 4.971
EU - Europa 1.201
SA - Sud America 467
Continente sconosciuto - Info sul continente non disponibili 459
AF - Africa 86
OC - Oceania 11
Totale 14.915
Nazione #
US - Stati Uniti d'America 6.932
TR - Turchia 1.782
SG - Singapore 1.292
CN - Cina 1.175
CA - Canada 721
IT - Italia 691
BR - Brasile 339
VN - Vietnam 280
EU - Europa 132
FR - Francia 102
IN - India 102
HK - Hong Kong 79
DE - Germania 67
GB - Regno Unito 61
IE - Irlanda 52
BD - Bangladesh 49
AR - Argentina 45
MX - Messico 40
ID - Indonesia 34
ES - Italia 32
RU - Federazione Russa 32
PK - Pakistan 30
FI - Finlandia 29
ZA - Sudafrica 28
PL - Polonia 24
UA - Ucraina 22
IQ - Iraq 21
JP - Giappone 18
IL - Israele 17
NL - Olanda 17
CO - Colombia 16
EC - Ecuador 16
CL - Cile 15
SE - Svezia 15
PH - Filippine 13
SA - Arabia Saudita 13
VE - Venezuela 13
MA - Marocco 12
SC - Seychelles 10
KE - Kenya 9
PY - Paraguay 9
AU - Australia 8
LT - Lituania 8
AE - Emirati Arabi Uniti 7
IR - Iran 7
KR - Corea 7
MY - Malesia 7
DK - Danimarca 6
TN - Tunisia 6
UY - Uruguay 6
UZ - Uzbekistan 6
CZ - Repubblica Ceca 5
EG - Egitto 5
JM - Giamaica 5
RO - Romania 5
BG - Bulgaria 4
BO - Bolivia 4
CR - Costa Rica 4
ET - Etiopia 4
JO - Giordania 4
LB - Libano 4
PE - Perù 4
TH - Thailandia 4
AL - Albania 3
BA - Bosnia-Erzegovina 3
HN - Honduras 3
NP - Nepal 3
PA - Panama 3
PT - Portogallo 3
SN - Senegal 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
AT - Austria 2
AZ - Azerbaigian 2
BB - Barbados 2
BS - Bahamas 2
BY - Bielorussia 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
GR - Grecia 2
KH - Cambogia 2
KZ - Kazakistan 2
LV - Lettonia 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
OM - Oman 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
AD - Andorra 1
AM - Armenia 1
BE - Belgio 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BW - Botswana 1
CD - Congo 1
DZ - Algeria 1
GD - Grenada 1
GE - Georgia 1
GH - Ghana 1
Totale 14.576
Città #
Kocaeli 1.570
San Mateo 1.183
Dallas 894
San Jose 834
Toronto 675
Rome 497
Ashburn 481
Singapore 345
Beijing 335
Wilmington 331
Houston 305
Santa Clara 285
Phoenix 273
Council Bluffs 265
Princeton 224
Lawrence 223
Chandler 168
Ho Chi Minh City 115
Fairfield 95
Seattle 88
Woodbridge 83
Shanghai 79
Los Angeles 78
Hong Kong 71
Hanoi 56
Guangzhou 53
Cambridge 41
New York 36
Brooklyn 35
The Dalles 30
Shenzhen 27
São Paulo 26
Frankfurt am Main 24
Chicago 23
Redwood City 23
Helsinki 22
Mexico City 20
Columbus 19
Islamabad 19
Dublin 17
Saint Petersburg 17
London 15
Netanya 15
Tokyo 15
Da Nang 14
Johannesburg 14
Warsaw 14
Atlanta 13
Milan 13
Montreal 13
Orem 13
Buffalo 12
Redmond 12
Rio de Janeiro 12
Wuhan 12
Xi'an 11
Jiaxing 10
Nanjing 10
Roubaix 10
Stockholm 10
Bandung 9
Brasília 9
Haiphong 9
Kyiv 9
San Francisco 9
Wuxi 9
Amsterdam 8
Ankara 8
Chennai 8
Manchester 8
Queens 8
Wroclaw 8
Boston 7
Charlotte 7
Curitiba 7
Denver 7
Hyderabad 7
Munich 7
Nairobi 7
Turku 7
Baghdad 6
Biên Hòa 6
Boardman 6
Changsha 6
Hải Dương 6
Jakarta 6
Las Vegas 6
Philadelphia 6
Quanzhou 6
Seoul 6
Tashkent 6
Washington 6
Zhengzhou 6
Belo Horizonte 5
Caracas 5
Guayaquil 5
Hefei 5
Jeddah 5
Medellín 5
Mumbai 5
Totale 10.494
Nome #
Angiogenesis and Hypertension: The Dual Role of Anti-Hypertensive and Anti-Angiogenic Therapies 144
Ketogenic Diet and Other Dietary Intervention Strategies in the Treatment of Cancer 136
RISK: A Random Optimization Interactive System Based on Kernel Learning for Predicting Breast Cancer Disease Progression 128
A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: A prospective longitudinal study 127
A reliable and reproducible technique for DNA Fingerprinting in Biorepositories: A Pilot Study from BioBIM 112
A Comprehensive Procedural Approach to Genotyping KRAS and BRAF from Paraffin Embedded Tissues for Diagnostic Purposes 112
Activation of blood coagulation in breast cancer - relationship to clinical outcome 107
Aging: an important risk factor in chemotherapy-associated vascular diseases 106
Look beyond Catechol-O-Methyltransferase genotype for cathecolamines derangement in migraine: the BioBIM rs4818 and rs4680 polymorphisms study 103
[New insights in the pathogenesis of prothrombotic state associated with hypercholesterolemia] 101
An importance of identification of double variant methylenetetrahydrofolate reductase gene C677T and A1298C in cis configuration for pharmacogenetic studies 97
A global assay sensitive to activated protein C abnormalities is predictive for chemotherapy-associated venous thromboembolism 95
Association between migraine and ACE gene (insertion/deletion) polymorphism: the BioBIM study 94
TAG-72 expression and its role in the biological evaluation of human colorectal cancer 90
An activated protein C-dependent thrombin generation assay predicts chemotherapy-associated venous thromboembolism in cancer patients 89
Postsurgical chemotherapy in stage IB nonsmall cell lung cancer: Long-term survival in a randomized study 88
Anoxia-Reoxygenation Enhances Platelet Thromboxane A2 Production via Reactive Oxygen Species-Generated NOX2 Effect in Patients Undergoing Elective Percutaneous Coronary Intervention 87
Acid citrate dextrose (ACD) formula A as a new anticoagulant in the measurement of in vitro platelet aggregation 84
A multiparametric index of platelet in vitro aggregation in cerebrovascular disease 84
Endothelial dysfunction and oxidative stress in arterial hypertension 82
“Personal and sensitive data in the e-health-IoT universe” 80
Neutrophil/lymphocyte ratio helps select metastatic pancreatic cancer patients benefitting from oxaliplatin 80
Absolute neutrophil counts and fibrinogen levels as an aid in the early diagnosis of acute myocardial infarction 79
Platelet activation, inflammatory mediators and hypercholesterolemia 78
Abnormal ventricular late potentials and in vivo platelet activation in Myotonic Dystrophy 78
Arterial hypertension and cardiovascular risk: need for a combined strategy of intervention 78
Role of interleukin-6 in the diagnosis of acute aortic dissection 76
Chronic obstructive pulmonary disease. A possible correlation between platelet aggregation tests and respiratory indexes. ECOB Group 76
Thromboembolic Events in Patients Treated with Anti-Angiogenic Drugs 76
Soluble P-selectin: A marker of platelet hyperactivity in patients with chronic obstructive pulmonary disease 75
CORRELATION BETWEEN POSITIVE CA-72-4 SERUM LEVELS AND LYMPH-NODE INVOLVEMENT IN PATIENTS WITH GASTRIC-CARCINOMA 75
Decreased plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus: association with oxidative stress and metabolic control 74
EFFECTS ON PLATELET-FUNCTION BY HUMAN INTERFERON-BETA IN CARCINOMA PATIENTS 74
Platelet activation in type 2 diabetes mellitus 74
Assay for the detection of anti-idiotypic antibodies to monoclonal antibody B72.3 74
ROLE OF TUMOR-CELL MEMBRANE GANGLIOSIDES IN PROMOTING PLATELET PROAGGREGATING ACTIVITY 74
EVALUATION OF THE CLINICAL UTILITY OF PLATELET-AGGREGATION STUDIES IN THE LONG-TERM FOLLOW-UP OF PATIENTS WITH ATHEROSCLEROTIC VASCULAR-DISEASE 73
Soluble CD40 ligand (sCD40L) plasma levels in non-small cell lung cancer 73
HEMOSTATIC BALANCE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE 73
Contribution of platelet-derived CD40 ligand to inflammation, thrombosis and neoangiogenesis 73
Enhanced interleukin-1 beta in hypercholesterolemia - Effects of simvastatin and low-dose aspirin 73
Impact of chemotherapy on activated protein C-dependent thrombin generation - association with venous thromboembolism occurrence 73
Machine learning approach to predict medication overuse in migraine patients 73
PD-L1 Is Highly Expressed in Malignant Mesothelioma and PD-1(+)Lymphocytes within Malignant Effusions Induce PD-L1 Expression 72
Effects of storage on in vitro platelet responses: Comparison of ACD and Na citrate anticoagulated samples 72
Ganglioside content of human platelets - Differences in resting and activated platelets 72
Higher oxidative stress in hepatitis C than hepatitis B virus cirrhotic patients 71
Interleukin-6 and haemostatic system in patients with chronic obstructive pulmonary disease 71
Radioimmunoscintigraphy of colon cancer with iodine-131-labeled B72.3 monoclonal antibody 71
TNFA Gene Promoter Polymorphisms and Susceptibility to Recurrent Pregnancy Loss in Italian Women 70
Evaluation of the CA 242 tumor antigen as a potential serum marker for colorectal cancer 70
Hypercoagulability state in patients with chronic obstructive pulmonary disease. Chronic Obstructive Bronchitis and Haemostasis Group 70
Artificial intelligence for cancer-associated thrombosis risk assessment 70
Predicting VTE in Cancer Patients: Candidate Biomarkers and Risk Assessment Models 70
Towards the Interpretability of Machine Learning Predictions for Medical Applications Targeting Personalised Therapies: A Cancer Case Survey 70
Trombofilia ereditaria e poliabortività: studio osservazionale in 150 pazienti 69
High-sensitive D-dimer Determination for the Prediction of Chemotherapy-associated Venous Thromboembolism in Lung Cancer Patients 69
Risk Assessment for Venous Thromboembolism in Chemotherapy-Treated Ambulatory Cancer Patients 69
Association of low-grade inflammation and platelet activation in patients with hypertension with microalbuminuria 69
Platinum-based compounds and risk for cardiovascular toxicity in the elderly: role of the antioxidants in chemoprevention 69
Ideal Body Mass Index (BMI) difference between curatively resected and metastatic colorectal cancer (CRC) patients on chemotherapy 69
Random optimization interactive system based on Kernel learning (RISK) for venous thromboembolism risk assessment in chemotherapy-treated cancer patients 68
Validation of a machine learning approach for venous thromboembolism risk prediction in oncology 68
Relation of Cytokine Production and Helicobacter Pylori Infection to Coronary Heart Disease 67
Novel High-sensitive D-dimer determination predicts chemotherapy-associated venous thromboembolism in cancer patients 67
Soluble E-selectin levels and CEA expressing blood-borne cells in colorectal cancer patients. A causal relationship? 67
CLINICAL-EVALUATION OF THE NEW TUMOR-MARKER TAG-72 67
The role of anti-CGRP antibodies in the pathophysiology of primary headaches 67
Circulating Biomarkers in Migraine: New Opportunities for Precision Medicine 67
Dopaminergic symptoms in migraine: A cross-sectional study on 1148 consecutive headache center-based patients 67
In vitro interactions between blood platelets and human colorectal tumor cells 66
Is CEA serum measurement useful in monitoring breast cancer patients? 66
Serum Metalloproteinase-9 Levels in Patients with Coronary Heart Disease A Novel Marker of Inflammation 66
Determinants of platelet activation in pulmonary arterial hypertension 66
IS THE CD54 PROTEIN (ICAM-1) INVOLVED IN PLATELET-TUMOR CELL-INTERACTION 66
Determinants of thromboxane biosynthesis in patients with moderate to severe chronic kidney disease 66
Low-density lipoprotein-lowering medication and platelet function 66
Onabotulinum toxin A in the treatment of chronic migraine: patient selection and special considerations 66
Association of LTA and SOD Gene Polymorphisms with Cerebral White Matter Hyperintensities in Migraine Patients 65
Establishment of a biorepository for migraine research: the experience of Interinstitutional Multidisciplinary BioBank (BioBIM) 65
CA 72-4 radioimmunoassay for the detection of the TAG-72 carcinoma-associated antigen in serum of patients 65
Vascular endothelial growth factor levels in melanoma Relationship with coagulation and platelet activation markers 65
Association between Migraine and Progesterone Receptor Gene PROGINS Polymorphism: the BioBIM study 65
Vascular endothelial growth factor (VEGF-A) plasma levels in non-small cell lung cancer: relationship with coagulation and platelet activation markers 65
NADPH OXIDASE-RELATED OXIDATIVE STRESS ENHANCES PLATELET THROMBOXANE PRODUCTION IN ASPIRIN-TREATED PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION 65
Potential artifact for the increase of tumor associated antigens in serum samples from patients injected with monoclonal antibodies 65
Combined evaluation of CA 242 and CEA tumor markers in the management of colorectal cancer 65
Breast Cancer Prognosis Using a Machine Learning Approach 65
Non-Communicable Diseases: Gender Differences in Therapy 64
Ideal Body Mass Index (BMI) is significantly different between curatively resected and metastatic colorectal cancer (CRC) patients on chemotherapy 64
Circulating Levels of Pro-Inflammatory Cytokines in Isolated Limb Perfusion 63
Increased plasma levels of soluble CD40 ligand correlate with platelet activation markers and underline the need for standardized pre-analytical conditions 63
Association between increased tumor necrosis factor alpha levels and acquired activated protein C resistance in patients with metastatic colorectal cancer 63
Correlation between platelet function and cytokine levels during hypothermic cardiopulmonary bypass 63
Association Between Birt Hogg Dube Syndrome and Cancer Predisposition 63
Clinical utility of CA 72-4 serum marker in the staging and immediate post-surgical management of gastric cancer patients 63
Malignant Mesothelioma Effusions Are Infiltrated by CD3(+) T Cells Highly Expressing PD-L1 and the PD-L1(+) Tumor Cells within These Effusions Are Susceptible to ADCC by the Anti-PD-L1 Antibody Avelumab 63
Effects of normothermic versus hypothermic cardiopulmonary bypass on cytokine production and platelet function 62
Changes of the lag phase of collagen-induced platelet aggregation in long-term aspirin therapy 62
Biomarkers of platelet activation in acute coronary syndromes 62
Totale 7.599
Categoria #
all - tutte 134.219
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 134.219


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.549 0 0 675 4 3 3 284 238 27 279 4 32
2022/2023841 490 18 18 54 33 11 2 35 31 65 84 0
2023/2024497 4 0 9 121 26 20 7 25 1 49 1 234
2024/20252.053 88 477 110 90 110 355 147 106 206 14 70 280
2025/20265.110 396 525 695 369 373 597 667 301 459 571 72 85
2026/2027965 61 617 287 0 0 0 0 0 0 0 0 0
Totale 14.915